Σάββας Σουρμελής Διευθυντής Β Ορθοπαιδικής Κλινικής ΔΘΚΑ «Υγεία» Αναγνώριση παραγόντων κινδύνου της φλεβικής θρόμβωσης.

Size: px
Start display at page:

Download "Σάββας Σουρμελής Διευθυντής Β Ορθοπαιδικής Κλινικής ΔΘΚΑ «Υγεία» Αναγνώριση παραγόντων κινδύνου της φλεβικής θρόμβωσης."

Transcription

1 Σάββας Σουρμελής Διευθυντής Β Ορθοπαιδικής Κλινικής ΔΘΚΑ «Υγεία» Αναγνώριση παραγόντων κινδύνου της φλεβικής θρόμβωσης.

2

3 VTE: deep vein thrombosis (DVT) and pulmonary embolism (PE) PE Migration Embolus Thrombus DVT

4 VTE: Often undetected until too late Over 70% of fatal PE are detected post mortem 1,3 Approximately 80% of DVTs are clinically silent 2,3

5 Venous thromboembolism (VTE) in Europe A. Cohen, G. Agneli et al Thromb. Haemost. 98: , 764, 2007

6 Number of VTE related deaths in EU per annum Breast cancer Prostate cancer Road traffic accidents AIDS

7 ENDORSE: VTE risk and prophylaxis in the acute hospital care setting a multinational cross-sectional sectional study Data from Cohen AT et al. Lancet 2008;371: countries 358 hospitals patients enrolled

8

9 Surgical Patients Acceptable surgical patients At-risk surgical patients At-risk surgical patients receiving any prophylaxis At-risk surgical patients receiving ACCP-recommended prophylaxis Germany % 94% 92% Greece % 74% 72% USA % 80% 71% Total % 64% 59%

10 Patients with VTE have unacceptably high short-term term mortality and long-term morbidity, which makes prevention of VTE paramount. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

11 Inadequate VTE risk assessment and delay to chemoprophylaxis carry independent and significant increased risk for VTE. Inadequate Venous Thromboembolism Risk Stratification Predicts Venous Thromboembolic Events in Surgical Intensive Care Unit Patients Christopher J Pannucci et al. J Am Coll Surg 4:1-7, 2014

12 Current VTE prophylaxis guidelines strongly promote risk assessment on the individual level. This score sums 7 risk factors into risk categories: Low Risk, 2-3 Moderate 2 risk, >=4 high risk. Validating the IMPROVE Venous Thromboembolism (VTE) Risk Score: Retrospective Analysis of Electronic Data From a Large Health System David Rosenberg et al. Chest. 145, 2014

13 Intensive care unit patients with VTE have in-icu mortality rates between 7% and 16% and in- hospital mortality rates between 10% and 28%. The 2005 Caprini score is currently the most widely used and well-validated RAM among surgical patients. Inadequate Venous Thromboembolism Risk Stratification Predicts Venous V Thromboembolic Events in Surgical Intensive Care Unit Patients Christopher J Pannucci et al. J Am Coll Surg 4:1-7, 2014

14

15 Risk assessment as a guide for the prevention of the many faces of venous thromboembolism Joseph A. Caprini, M.D. The American Journal of Surgery :199,Suppl. January 2010

16 Risk assessment as a guide for the prevention of the many faces of venous thromboembolism Joseph A. Caprini, M.D. The American Journal of Surgery :199,Suppl. January 2010

17 Risk assessment as a guide for the prevention of the many faces of venous thromboembolism Joseph A. Caprini, M.D. The American Journal of Surgery :199,Suppl. January 2010

18 Perioperative VTE risk among surgical patients varies by 20-fold, which highlights the importance of risk stratification to identify high- risk patients, in whom chemoprophylaxis can decrease VTE risk, and low-risk patients, for whom the risk-benefit relationship of prophylaxis may be unfavorable. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

19 Models that predict VTE risk based on pre-, intra-,, and postoperative events. can predict a patient s s VTE risk only at the end of their hospitalization, when the opportunity for acute prophylaxis has passed. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

20 The perceived risk of hemorrhage is a recognized barrier to physicians providing chemoprophylaxis after surgery. We recommend that further work present data on the risk-stratified stratified response to prophylaxis side by side with the risks stratified data on bleeding complications. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

21 The Caprini score was created based on expert opinion > 20 years ago but has subsequently been validated retrospectively in multiple populations. However, the model requires yes/no answers to 40 risk factor questions, which may limit physician compliance with completion. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

22 Reduced models with fewer risk factors have been shown to predict risk similarly to full models. The goal of this study was to create a risk- prediction tool that could risk stratify patients prior to surgery. A Validated Risk Model to Predict 90-Day VTE Events in Postsurgical Patients Christopher J. Pannucci et al CHEST 145:3, MARCH 2014

23 Both of the studied RAMs had high specificities and positive-predictive predictive values, minimizing the risk of overprophylaxis. Improving the sensitivity of such RAMs can help for timely risk assessment for a greater array of real-world patients. Comparison of three risk assessment methods for venous thromboembolism bolism prophylaxis. Behnood Bikdeli et al Wolters Kluwer Health Lippincott Williams & Wilkins

24 This study supports that the 3 category RAM can reliably differentiate low risk patients from those at higher risk for a hospital acquired VTE. It may be reasonable to withhold prophylaxis from low risk patients. Validating the IMPROVE Venous Thromboembolism (VTE) Risk Score: Retrospective Analysis of Electronic Data From a Large Health System David Rosenberg et al. Chest. 145, 2014

25

26 VTE in orthopedic surgery: A major risk for fatal PE Major lower limb surgery: A very high VTE risk on its own, whatever the accompanying risk factors 1,2 VTE rates without prophylaxis Elective hip replacement Total knee replacement Hip fracture % DVT rate (range) % Fatal PE (range)

27

28

29

30

31

32

33

Boston Experience: Benchmark for the Nation

Boston Experience: Benchmark for the Nation Boston Experience: Benchmark for the Nation NSQIP Surgeon Champion Call January 22, 2015 David McAneny MD, FACS Vice Chair, Department of Surgery I have no relevant financial relationships or conflicts

More information

Boston Experience: Benchmark for the Nation

Boston Experience: Benchmark for the Nation Boston Experience: Benchmark for the Nation 2014 ACS NSQIP National Conference Venous Thromboembolism (Breakout Session 2) New York, NY July 28, 2014 David McAneny MD, FACS Vice Chair, Department of Surgery

More information

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies VTE in Surgical Patients: Recognizing the Patients at Risk Pathogenesis of thrombosis: Virchow s triad and VTE Risk Hypercoagulability

More information

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures 1 Predicting Venous Thromboembolic Complications following Neurosurgical Procedures David Dornbos III, Varun Shah, Blake Priddy, Victoria Schunemann, Ciarán Powers Venous Thromboembolic (VTE) Complications

More information

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS

AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS The West London Medical Journal 2010 Vol 2 No 4 pp 19-24 AN AUDIT: THROMBOPROPHYLAXIS FOR TOTAL HIP REPLACEMENT PATIENTS AT NORTHWICK PARK AND CENTRAL MIDDLESEX HOSPITALS Soneji ND Agni NR Acharya MN Anjari

More information

VTE in the Trauma Population

VTE in the Trauma Population VTE in the Trauma Population Erik Peltz, D.O. February 11 th, 2015 * contributions from Eduardo Gonzalez, M.D. University of Colorado T-32 Research Fellow The problem. VTE - Scope of the Problem One of

More information

Protocol. Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Protocol. Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for (10128) (Formerly Outpatient Use of Limb Pneumatic Compression Devices for ) Medical Benefit Effective Date: 07/01/14 Next Review Date: 03/15

More information

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008 Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski Department of Surgery Grand Rounds March 24, 2008 History of Vena Cava Filters Virchow-1846-Proposes PE originate from veins

More information

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis Top Ten Reasons For Failure To Prevent Postoperative Thrombosis Joseph A. Caprini, MD, MS, FACS, RVT, FACCWS Louis W. Biegler Chair of Surgery NorthShore University HealthSystem, Evanston, IL Clinical

More information

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk?

Objectives. Venous Thromboembolism (VTE) Prophylaxis. Case VTE WHY DO IT? Question: Who Is At Risk? Objectives Venous Thromboembolism (VTE) Prophylaxis Rishi Garg, MD Department of Medicine Identify patients at risk for VTE Options for VTE prophylaxis Current Recommendations (based on The Seventh ACCP

More information

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS PROPHYLAXIS Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs are dependent

More information

Primary VTE Prophylaxis. Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand

Primary VTE Prophylaxis. Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand Primary VTE Prophylaxis Ponlapat Rojnuckarin, MD PhD Chulalongkorn University Bangkok, Thailand A 70-yr-old female before THA BMI 31 kg/m 2 with varicose vein What do you recommend for VTE prevention?

More information

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT OBJECTIVE: To provide guidance on the recommended duration of anticoagulant therapy for venous thromboembolism (VTE). BACKGROUND: Recurrent episodes of VTE

More information

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY

Results from RE-COVER RE-COVER II RE-MEDY RE-SONATE EXECUTIVE SUMMARY Assessment of the safety and efficacy of dabigatran etexilate (Pradaxa ) in the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and the prevention of recurrent DVT and PE Results from

More information

CADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm

CADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm CADTH Rapid Response Report: ASA for Venous Thromboembolism Prophylaxis: Evidence for Clinical Benefit and Harm P. Timothy Pollak, MD, PhD University of Calgary Rocky Mountain/ACP Internal Medicine Meeting,

More information

Prevalence of Symptomatic Venous Thrombo-Embolism in Patients with Total Contact Cast for Diabetic foot Complications A Retrospective Case Series.

Prevalence of Symptomatic Venous Thrombo-Embolism in Patients with Total Contact Cast for Diabetic foot Complications A Retrospective Case Series. Prevalence of Symptomatic Venous Thrombo-Embolism in Patients with Total Contact Cast for Diabetic foot Complications A Retrospective Case Series. Dr R King, Miss GE Jackson, Mr SR Platt Wirral University

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Postsurgical Home Use of Limb Compression Devices for Venous File Name: Origination: Last CAP Review: Next CAP Review: Last Review: postsurgical_home_use_of_limb_ compression_devices_for_vte_prophylaxis

More information

Misunderstandings of Venous thromboembolism prophylaxis

Misunderstandings of Venous thromboembolism prophylaxis Misunderstandings of Venous thromboembolism prophylaxis Veerendra Chadachan Senior Consultant Dept of General Medicine (Vascular Medicine and Hypertension) Tan Tock Seng Hospital, Singapore Case scenario

More information

Venous Thromboembolism. Prevention

Venous Thromboembolism. Prevention Venous Thromboembolism Prevention August 2010 Venous Thromboembloism Prevention 1 1 Expected Practice Assess all patients upon admission to the ICU for risk factors of venous thromboembolism (VTE) and

More information

Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol

Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol Patterns of Failure of a Standardized Perioperative Venous Thromboembolism Prophylaxis Protocol Ryan Macht MD, Michael Cassidy MD, Pamela Rosenkranz RN BSN MEd, Joseph Caprini MD FACS, David McAneny MD

More information

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Clinical Position Statement Postsurgical Home Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Effective: October 2017 Next Review: September 2018 CLINICAL POSITION STATEMENT Postsurgical

More information

THE CHALLENGES OF COMPLIANCE WITH VTE PROPHYLAXIS GUIDELINES. Pr I. ELALAMY Service d Hématologie Biologique HOPITAL TENON ER2 UPMC PARIS

THE CHALLENGES OF COMPLIANCE WITH VTE PROPHYLAXIS GUIDELINES. Pr I. ELALAMY Service d Hématologie Biologique HOPITAL TENON ER2 UPMC PARIS THE CHALLENGES OF COMPLIANCE WITH VTE PROPHYLAXIS GUIDELINES Pr I. ELALAMY Service d Hématologie Biologique HOPITAL TENON ER2 UPMC PARIS VTE Commonest avoidable cause of hospital death Patient safety issue

More information

Anticoagulation for prevention of venous thromboembolism

Anticoagulation for prevention of venous thromboembolism Anticoagulation for prevention of venous thromboembolism Original article by: Michael Tam Note: updated in June 2009 with the eighth edition (from the seventh) evidence-based clinical practice guidelines

More information

Risk Modeling Using Large Datasets An examination of VTE after outpatient surgery

Risk Modeling Using Large Datasets An examination of VTE after outpatient surgery Risk Modeling Using Large Datasets An examination of VTE after outpatient surgery Christopher Pannucci MD MS, Amy Shanks MS, Marc Moote PA-C, Vinita Bahl DMD, Paul Cederna MD, Norah Naughton MD, Thomas

More information

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients David Liff MD Oklahoma Heart Institute Vascular Center Overview Pathophysiology of DVT Epidemiology and risk factors for DVT in the

More information

Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials

Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials Winner of the AAHKS Award Venous Thromboembolism Prophylaxis After Major Orthopaedic Surgery: A Pooled Analysis of Randomized Controlled Trials Greg A. Brown, MD, PhD The Journal of Arthroplasty Vol. 24

More information

Venous Thrombosis in Asia

Venous Thrombosis in Asia Venous Thrombosis in Asia Pantep Angchaisuksiri, M.D. Professor of Medicine, Mahidol University, Thailand Adjunct Associate Professor, University of North Carolina, Chapel Hill, USA Venous Thromboembolism

More information

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence

Incidence of DVT Post- Hip or Knee Replacement. A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence Incidence of DVT Post- Hip or Knee Replacement A Comparison of Incidence at Boundary Trails Health Centre to a Credible Baseline Incidence Background DVTs Pulmonary Embolisms Death Symptomatic DVTs (leg

More information

Pharmacy Prior Authorization

Pharmacy Prior Authorization Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Anticoagulant Injectable (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review

More information

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM Gordon Lowe Professor of Vascular Medicine University of Glasgow VENOUS THROMBOEMBOLISM Common cause of death and disability 50% hospital-acquired

More information

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal

Understanding thrombosis in venous thromboembolism. João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Understanding thrombosis in venous thromboembolism João Morais Head of Cardiology Division and Research Centre Leiria Hospital Centre Portugal Disclosures João Morais On the last year JM received honoraria

More information

Dr Fahad Al-Hameed MD, FCCP, FRCPC Consultant Intensivist & Pulmonologist Professor Asst. of Medicine/Critical Care KSAU-HS Deputy chairman,

Dr Fahad Al-Hameed MD, FCCP, FRCPC Consultant Intensivist & Pulmonologist Professor Asst. of Medicine/Critical Care KSAU-HS Deputy chairman, Dr Fahad Al-Hameed MD, FCCP, FRCPC Consultant Intensivist & Pulmonologist Professor Asst. of Medicine/Critical Care KSAU-HS Deputy chairman, Intensive Care Department, Director, Ambulatory Care Center

More information

Challenges in Anticoagulation and Thromboembolism

Challenges in Anticoagulation and Thromboembolism Challenges in Anticoagulation and Thromboembolism Ethan Cumbler M.D. Assistant Professor of Medicine Hospitalist Medicine Section University of Colorado Denver May 2010 No Conflicts of Interest Objectives

More information

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE)

DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) DVT PROPHYLAXIS IN HOSPITALIZED MEDICAL PATIENTS SAURABH MAJI SR (PULMONARY,MEDICINE) Introduction VTE (DVT/PE) is an important complication in hospitalized patients Hospitalization for acute medical illness

More information

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients?

What evidence exists that describes the efficacy of mechanical prophylaxis for venous thromboembolism (VTE) in adult surgical patients? July 2015 Rapid Review Evidence Summary McGill University Health Centre: Division of Nursing Research and MUHC Libraries What evidence exists that describes the efficacy of mechanical prophylaxis for venous

More information

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Page: 1 of 13. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Last Review Status/Date: March 2014 Page: 1 of 13 Compression Devices for Venous Description Patients undergoing major orthopedic surgery are at increased risk for venous thromboembolism (VTE). Patients

More information

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Policy Number: 1.01.28 Last Review: 4/2018 Origination: 4/2013 Next Review: 4/2019 Policy Blue Cross and Blue

More information

Thromboembolism and cancer: New practices. Marc Carrier

Thromboembolism and cancer: New practices. Marc Carrier Thromboembolism and cancer: New practices Marc Carrier Marc Carrier Research Support/P.I. Employee Consultant Major Stockholder Speakers Bureau Honoraria Scientific Advisory Board Leo Pharma, BMS No relevant

More information

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms DATE: 23 August 2011 CONTEXT AND POLICY ISSUES: Thromboembolism occurs when a blood

More information

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study IMPROVING PATIENT SAFETY Preventing & Managing Venous Thromboembolism Session 8 Data Driving Strategies for VTE Prevention and Management 3/30/2012; 15.35-15.55 Symptomatic Venous Thromboembolism after

More information

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Slide 1. Slide 2. Slide 3. Outline of This Presentation Slide 1 Current Approaches to Venous Thromboembolism Prevention in Orthopedic Patients Hujefa Vora, MD Maria Fox, RN June 9, 2017 Slide 2 Slide 3 Outline of This Presentation Pathophysiology of venous

More information

Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative

Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative JBUON 2018; 23(1): 248-254 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Incidence and risk assessment of venous thromboembolism in cancer patients

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

Cover Page. The handle holds various files of this Leiden University dissertation.

Cover Page. The handle  holds various files of this Leiden University dissertation. Cover Page The handle http://hdl.handle.net/1887/21764 holds various files of this Leiden University dissertation. Author: Mos, Inge Christina Maria Title: A more granular view on pulmonary embolism Issue

More information

Venous Thromboembolism National Hospital Inpatient Quality Measures

Venous Thromboembolism National Hospital Inpatient Quality Measures Venous Thromboembolism National Hospital Inpatient Quality Measures Presentation Overview Review venous thromboembolism as a new mandatory measure set Outline measures with exclusions and documentation

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement Marilyn Szekendi, PhD, RN ANA 7 th Annual Nursing Quality Conference, February 2013 Research Team Banafsheh Sadeghi,

More information

Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis?

Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from root-cause analysis? TRAUMA AND ORTHOPAEDIC SURGERY Ann R Coll Surg Engl 2016; 98: 538 542 doi 10.1308/rcsann.2016.0202 Venous thromboembolism after total knee replacement or total hip replacement: what can be learnt from

More information

Inferior Vena Cava Filters

Inferior Vena Cava Filters Inferior Vena Cava Filters and the American Society of Hematology Choosing Wisely Campaign Kevin P. Hubbard, DO, HMDC MACOI Chief - Division of Specialty Medicine Professor and Chair - Section of Internal

More information

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14 THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical

More information

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM International Consensus Statement 2013 Guidelines According to Scientific Evidence Developed under the auspices of the: Cardiovascular Disease Educational

More information

Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative

Incidence and risk assessment of venous thromboembolism in cancer patients admitted to intensive care unit for postoperative JBUON 2018; 23(2): 500-506 ISSN: 1107-0625, online ISSN: 2241-6293 www.jbuon.com E-mail: editorial_office@jbuon.com ORIGINAL ARTICLE Incidence and risk assessment of venous thromboembolism in cancer patients

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form. Performance Measure Name: Venous Thromboembolism Prophylaxis

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form. Performance Measure Name: Venous Thromboembolism Prophylaxis Last Updated: Version 4.3 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Venous Thromboembolism (VTE) Set Measure Set I #: Performance Measure Name: Venous

More information

Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore

Epidemiology of Venous Thromboembolism in the East. Heng Joo NG Department of Haematology Singapore General Hospital Singapore Epidemiology of Venous Thromboembolism in the East Heng Joo NG Department of Haematology Singapore General Hospital Singapore Early Literature Tinckler LF Br Med J 1964;1:502 Propagating a notion.. Hwang

More information

Connecticut Joint Replacement Institute (CJRI) Outcomes Report

Connecticut Joint Replacement Institute (CJRI) Outcomes Report Connecticut Joint Replacement Institute () Outcomes Report Our Highlights: Nationally recognized Over 27,000 surgeries performed Devoted to excellence in patient care Proven superior outcomes that matter.

More information

Factor Xa Inhibition in the Management of Venous Thromboembolism: Important Safety Information. Important Safety Information (cont d)

Factor Xa Inhibition in the Management of Venous Thromboembolism: Important Safety Information. Important Safety Information (cont d) Factor Xa Inhibition in the Management of Venous Thromboembolism: The Role of Fondaparinux WARNING: SPINAL/EPIDURAL HEMATOMAS Epidural or spinal hematomas may occur in patients who are anticoagulated with

More information

Perioperative Management of the Anticoagulated Patient

Perioperative Management of the Anticoagulated Patient Perioperative Management of the Anticoagulated Patient Citywide Resident Perioperative Medical Consultation Conference 5/5/17 Matthew Eisen, MD Director, Anticoagulation Services MetroHealth Medical Center

More information

Page: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Page: 1 of 14. Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Subject: Post-Surgical Outpatient Use of Limb Page: 1 of 14 Last Review Status/Date: March 2015 Post-Surgical Outpatient Use of Limb Compression Devices for Venous Description Patients undergoing major

More information

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge

Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge Reducing the risk of venous thrombo-embolism (VTE) in hospital and after discharge What is a venous thromboembolism (VTE)? This is a medical term that describes a blood clot that develops in a deep vein

More information

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Medical Policy An independent licensee of the Blue Cross Blue Shield Association Postsurgical Home Use of Limb Compression Devices Page 1 of 20 Medical Policy An independent licensee of the Blue Cross Blue Shield Association Title: See Also: Postsurgical Home Use of Limb Compression

More information

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Postsurgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Policy Number: 1.01.28 Last Review: 4/2019 Origination: 4/2013 Next Review: 4/2020 Policy Blue Cross and Blue

More information

Is There a Role for Prophylaxis in Cancer Patients During Therapy?

Is There a Role for Prophylaxis in Cancer Patients During Therapy? Victor F. Tapson, MD, FCCP, FRCP Professor of Medicine Director, Center for Pulmonary Vascular Disease Division of Pulmonary and Critical Care Duke University Medical Center Durham, N.C. USA Is There a

More information

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons Original Article Knee Surg Relat Res 2016;28(3):207-212 http://dx.doi.org/10.5792/ksrr.2016.28.3.207 pissn 2234-0726 eissn 2234-2451 Knee Surgery & Related Research Prophylaxis for Venous Thromboembolism

More information

Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty: The EPCAT II Trial

Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty: The EPCAT II Trial Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty: The EPCAT II Trial Wednesday, June 6, 2018, 2:00PM ET Guest Author: David R. Anderson, MD Presenter: Sara Vazquez, PharmD Moderators:

More information

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital

Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital Venous Thromboembolism Prophylaxis - Why Should We Care? Harry Gibbs FRACP FCSANZ Vascular Physician The Alfred Hospital VTE is common and dangerous 5 VTE is Common VTE Incidence: 1.5 / 1000 per year

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Last Updated: Version 4.3 NQF-ENORSE VOLUNTARY CONSENSUS STANARS FOR HOSPITAL CARE Measure Information Form Measure Set: Venous Thromboembolism (VTE) Set Measure Set I #: Performance Measure Name: Intensive

More information

Risk of Venous Thromboembolism Outweighs Post-Hepatectomy Bleeding Complications: Analysis of 5,651 NSQIP Patients

Risk of Venous Thromboembolism Outweighs Post-Hepatectomy Bleeding Complications: Analysis of 5,651 NSQIP Patients Risk of Venous Thromboembolism Outweighs Post-Hepatectomy Bleeding Complications: Analysis of 5,651 NSQIP Patients Ching-Wei D. Tzeng, MD Matthew H. G. Katz, MD; Jason B. Fleming, MD; Peter W. T. Pisters,

More information

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction

Adam Goldfarb, M.A., D.C., D.E.S.S. Introduction Venous Thromboembolism Prophylaxis following Lower Extremity Orthopedic Surgery: A Review of the Biomedical Research Literature and Evidence-Based Policy in the United States. Adam Goldfarb, M.A., D.C.,

More information

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS

SUBJECT: LIMB PNEUMATIC COMPRESSION EFFECTIVE DATE: 06/27/13 DEVICES FOR VENOUS REVISED DATE: 06/26/14, 09/15/15,09/21/17. THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY REVISED DATE: 06/26/14, 09/15/15,09/21/17. PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases,

More information

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS MEDICAL POLICY SUBJECT: LIMB PNEUMATIC COMPRESSION REVISED DATE: 06/26/14, 10/15/15, 06/16/16, PAGE: 1 OF: 5 If a product excludes coverage for a service, it is not covered, and medical policy criteria

More information

PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING

PNEUMATIC COMPRESSION DEVICES IN THE HOME SETTING Status Active Medical and Behavioral Health Policy Section: Medicine Policy Number: II-60 Effective Date: 05/19/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members should

More information

Robert X. Murphy Jr., MD, Task Force Chair DeLaine Schmitz, Sr. Director of Quality Initiatives Karie Rosolowski, Sr.

Robert X. Murphy Jr., MD, Task Force Chair DeLaine Schmitz, Sr. Director of Quality Initiatives Karie Rosolowski, Sr. American Society Of Plastic Surgeons 444 East Algonquin Road Arlington Heights, IL 65-4664 847-228-99 www.plasticsurgery.org Evidence-based Practices for Thromboembolism Prevention: A Report from the ASPS

More information

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery DOI 10.1186/s40064-016-2724-1 RESEARCH The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery Yuan Gao 1, Anhua Long 2,3, Zongyan Xie

More information

Audit of perioperative management of patients with fracture neck of femur

Audit of perioperative management of patients with fracture neck of femur Audit of perioperative management of patients with fracture neck of femur *M Dissanayake 1, N Wijesuriya 2 Registrar in Anaesthesia 1, Consultant Anaesthetist 2, North Colombo Teaching Hospital, Ragama,

More information

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press) Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN 0140-6736 (In Press) Access from the University of Nottingham repository: http://eprints.nottingham.ac.uk/1087/1/lancet_clots_1_20090522_4.pdf

More information

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton

Dr. Steve Ligertwood Dr. Roderick Tukker Dr. David Wilton Dr. Steve Ligertwood Hospitalist Royal Columbian Hospital Regional Department Head-Hospitalist for Fraser Health Authority Project Lead BC Hospitalist VTE Collaborative Clinical Instructor, UBC School

More information

Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI

Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI Measurement and Improvement of Quality of Cardiovascular Care DR : DEHESTANI Hospitals For hospitals in the United States, measures of cardiovascular care mandated by the Joint Commission have recently

More information

Landmark Phase III Study of Bayer s Xarelto (Rivaroxaban) Initiated for the Secondary Prevention of Myo

Landmark Phase III Study of Bayer s Xarelto (Rivaroxaban) Initiated for the Secondary Prevention of Myo Xarelto (Rivaroxaban) Landmark Phase III Study of Bayer s Xarelto (Rivaroxaban) Initiated for the Secondary Prevention of Myocardial Infarction and Death in Patients with Coronary or Peripheral Artery

More information

ASSESSMENT OF EFFECTIVENESS

ASSESSMENT OF EFFECTIVENESS W.M. Glinkowski 1,2,3,A.Górecki 1 WEB BASED DATABASE FOR THE ASSESSMENT OF EFFECTIVENESS OF THROMBOEMBOLIC PROPHYLAXIS IN ORTHOPAEDIC SURGERY. PRELIMINARY STUDY 1 Chair and Department of Orthopaedics and

More information

Aspirin as Venous Thromboprophylaxis

Aspirin as Venous Thromboprophylaxis Canadian Society of Internal Medicine Nov 2, 2017 Aspirin as Venous Thromboprophylaxis Bill Geerts, MD, FRCPC Thromboembolism Consultant, Sunnybrook HSC Professor of Medicine, University of Toronto Disclosures

More information

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC

Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC Canadian Society of Internal Medicine Annual Meeting 2016 Montreal, QC 1 st workshop: update to VTE guidelines in 2016 2 nd workshop: VTE controversies + new horizons André Roussin MD, FRCP, CSPQ CHUM

More information

Drug Class Review Newer Oral Anticoagulant Drugs

Drug Class Review Newer Oral Anticoagulant Drugs Drug Class Review Newer Oral Anticoagulant Drugs Final Original Report May 2016 The purpose of reports is to make available information regarding the comparative clinical effectiveness and harms of different

More information

Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis

Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Post-Surgical Outpatient Use of Limb Compression Devices for Venous Thromboembolism Prophylaxis Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary,

More information

Perioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014

Perioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014 Perioperative VTE prophylaxis (ACCP 9 th edition Guidelines) Gamal Marey SUNY Downstate Medical Center 10/16/2014 Case Presentation 75 y/o AAM Rectal bleeding & obstructive symptoms 11/12 Obstructing mass

More information

Ovid: A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Me... Page 1 of 18

Ovid: A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Me... Page 1 of 18 Ovid: A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Me... Page 1 of 18 Annals of Surgery Issue: Volume 251(2), February 2010, pp 344-350 Copyright: 2010 Lippincott Williams

More information

Diagnostic Algorithms in VTE

Diagnostic Algorithms in VTE Diagnostic Algorithms in VTE Mark H. Meissner, MD Department of Surgery University of Washington School of Medicine Overutilization of Venous Duplex U/S 1983-1993 (Zweibel et al, Australasian Rad, 1995)

More information

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE

Individualizing VTE Treatment and Prevention of Recurrence: The Place for Direct Oral Anticoagulants in VTE Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including

More information

Anesthesia for Total Hip and Knee Arthroplasty

Anesthesia for Total Hip and Knee Arthroplasty Anesthesia for Total Hip and Knee Arthroplasty Typical approach Describe anesthesia technique Rather Describe issues with THA and TKA How anesthesia can modify Issues Total Hip Total Knee Blood Loss ++

More information

Results from Hokusai-VTE presented during ESC Congress 2013 Hot Line session and published in the New England Journal of Medicine

Results from Hokusai-VTE presented during ESC Congress 2013 Hot Line session and published in the New England Journal of Medicine Press Release Daiichi Sankyo s Once-Daily Edoxaban Shows Comparable Efficacy and Superiority for the Principal Safety Endpoint Compared to Warfarin in a Phase 3 Study for the Treatment of Symptomatic VTE

More information

venous thromboembolism

venous thromboembolism Venous thromboembolism reduction initiative: A multifaceted collaborative effort to protect Intermountain Healthcare patients from hospitalassociated venous thromboembolism (HA-VTE) 14 th Annual Research

More information

Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery

Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery Incidence of Symptomatic Pulmonary Embolism in Spinal Surgery Chatupon Chotigavanichaya MD*, Monchai Ruangchainikom MD*, Choompon Piyavanno MD*, Ekkapoj Korwutthikulrangsri MD*, Sirichai Wilartratsami

More information

Updates in Management of Venous Thromboembolic Disease

Updates in Management of Venous Thromboembolic Disease Updates in Management of Venous Thromboembolic Disease November 7 th 2018 UHN Emergency Conference Susan Jenkins RN(EC) NP-Adult Thrombosis and Hemostasis Program University Health Network Disclosures

More information

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales Merimbula, 6 th November 2010 University of Sydney Department of Surgery Westmead Hospital

More information

New Oral Anticoagulants in treatment of VTE, PE DR.AMR HANAFY (LECTURER OF CARDIOLOGY ) ASWAN UNIVERSITY

New Oral Anticoagulants in treatment of VTE, PE DR.AMR HANAFY (LECTURER OF CARDIOLOGY ) ASWAN UNIVERSITY New Oral Anticoagulants in treatment of VTE, PE DR.AMR HANAFY (LECTURER OF CARDIOLOGY ) ASWAN UNIVERSITY Fact VTE is deadly! It nibbles after it bites! The 30-day mortality rates for first-time DVT or

More information

Intervention for Deep Venous Thrombosis and Pulmonary Embolus

Intervention for Deep Venous Thrombosis and Pulmonary Embolus Intervention for Deep Venous Thrombosis and Pulmonary Embolus Michael R. Jaff, DO Paul and Phyllis Fireman Endowed Chair in Vascular Medicine Massachusetts General Hospital Professor of Medicine Harvard

More information

-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD

-DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD -DVT and PE Reduction Strategy in AWR- Can We Win? Luciano Tastaldi, MD Summary of the Project Objectives Present Numbers Evolution Challenges of Implementation Discuss Future Directions -Problem at CCF-

More information

Discussion Leader: Doug Bias, M.D.

Discussion Leader: Doug Bias, M.D. In low-risk patients with isolated calf DVT (IDDVT), what is the morbidity risk of treating with repeat ultrasound/observation versus anticoagulation? Discussion Leader: Doug Bias, M.D. Clinical Scenario:

More information

ORIGINAL ARTICLES SECTION II. Prevalence and Risk Factors for Symptomatic Thromboembolic Events after Shoulder Arthroplasty

ORIGINAL ARTICLES SECTION II. Prevalence and Risk Factors for Symptomatic Thromboembolic Events after Shoulder Arthroplasty CLINICAL ORTHOPAEDICS AND RELATED RESEARCH Number 448, pp. 152 156 2006 Lippincott Williams & Wilkins SECTION II ORIGINAL ARTICLES Prevalence and Risk Factors for Symptomatic Thromboembolic Events after

More information

Venous thromboembolism (VTE) is a leading

Venous thromboembolism (VTE) is a leading Original Research Venous Thromboembolism Prophylaxis and the Impact of Standardized Guidelines: Is a Computer-Based Approach Enough? Muhammad Bilal Quraishi, MD, Robert Mathew, DO, Alicia Lowes, MD, Chowdry

More information

Cover Page. The handle holds various files of this Leiden University dissertation

Cover Page. The handle   holds various files of this Leiden University dissertation Cover Page The handle http://hdl.handle.net/1887/40114 holds various files of this Leiden University dissertation Author: Exter, Paul L. den Title: Diagnosis, management and prognosis of symptomatic and

More information